[Progressive renal diseases: recent advances in diagnosis and treatments. Topics: II. Pathophysiology and treatments; 6. Membranoproliferative glomerulonephritis].

作者: Shin Goto , Ichiei Narita

DOI: 10.2169/NAIKA.102.1145

关键词:

摘要:

参考文章(14)
A. Servais, V. Fremeaux-Bacchi, M. Lequintrec, R. Salomon, J. Blouin, B. Knebelmann, J.-P. Grunfeld, P. Lesavre, L.-H. Noel, F. Fakhouri, Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome Journal of Medical Genetics. ,vol. 44, pp. 193- 199 ,(2006) , 10.1136/JMG.2006.045328
Penina Tarshish, Jay Bernstein, Jonathan N. Tobin, Chester M. Edelmann, Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisone--a report of the International Study of Kidney Disease in Children. Pediatric Nephrology. ,vol. 6, pp. 123- 130 ,(1992) , 10.1007/BF00866289
Sanjeev Sethi, Fernando C. Fervenza, Membranoproliferative Glomerulonephritis — A New Look at an Old Entity The New England Journal of Medicine. ,vol. 366, pp. 1119- 1131 ,(2012) , 10.1056/NEJMRA1108178
Tetsuya Kawamura, Joichi Usui, Koji Kaseda, Kenji Takada, Itaru Ebihara, Takashi Ishizu, Tadashi Iitsuka, Kentaro Sakai, Katsumi Takemura, Masaki Kobayashi, Akio Koyama, Katsuyoshi Kanemoto, Ryo Sumazaki, Noriko Uesugi, Masayuki Noguchi, Michio Nagata, Machi Suka, Kunihiro Yamagata, Primary membranoproliferative glomerulonephritis on the decline: decreased rate from the 1970s to the 2000s in Japan Clinical and Experimental Nephrology. ,vol. 17, pp. 248- 254 ,(2013) , 10.1007/S10157-012-0690-7
Sandra Habbig, Michael J Mihatsch, Stefan Heinen, Bodo Beck, Mathias Emmel, Christine Skerka, Michael Kirschfink, Bernd Hoppe, Peter F Zipfel, Christoph Licht, None, C3 deposition glomerulopathy due to a functional factor H defect. Kidney International. ,vol. 75, pp. 1230- 1234 ,(2009) , 10.1038/KI.2008.354
Fadi Fakhouri, Véronique Frémeaux-Bacchi, Laure-Hélène Noël, H. Terence Cook, Matthew C. Pickering, C3 glomerulopathy: a new classification Nature Reviews Nephrology. ,vol. 6, pp. 494- 499 ,(2010) , 10.1038/NRNEPH.2010.85
Sanjeev Sethi, Carla M. Nester, Richard J.H. Smith, Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion Kidney International. ,vol. 81, pp. 434- 441 ,(2012) , 10.1038/KI.2011.399
Andrew S. Bomback, Gerald B. Appel, Pathogenesis of the C3 glomerulopathies and reclassification of MPGN Nature Reviews Nephrology. ,vol. 8, pp. 634- 642 ,(2012) , 10.1038/NRNEPH.2012.213
Rubén Martínez-Barricarte, Meike Heurich, Francisco Valdes-Cañedo, Eduardo Vazquez-Martul, Eva Torreira, Tamara Montes, Agustín Tortajada, Sheila Pinto, Margarita Lopez-Trascasa, B. Paul Morgan, Oscar Llorca, Claire L. Harris, Santiago Rodríguez de Córdoba, Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation Journal of Clinical Investigation. ,vol. 120, pp. 3702- 3712 ,(2010) , 10.1172/JCI43343
Elsa Guiard, Alexandre Karras, Emmanuelle Plaisier, Jean-Paul Duong Van Huyen, Fadi Fakhouri, Jean-Philippe Rougier, Laure-Hélène Noel, Patrice Callard, Michel Delahousse, Pierre Ronco, Patterns of noncryoglobulinemic glomerulonephritis with monoclonal Ig deposits: correlation with IgG subclass and response to rituximab. Clinical Journal of The American Society of Nephrology. ,vol. 6, pp. 1609- 1616 ,(2011) , 10.2215/CJN.10611110